Skip to Main content Skip to Navigation
Journal articles

High sensitivity of the Hematoflow™ solution for chronic myelomonocytic leukemia screening

Abstract : Background: Accumulation of classical monocytes CD14++CD16– (also called MO1) ≥ 94% can accurately distinguish chronic myelomonocytic leukemia (CMML) from reactive monocytosis. The HematoFlow™ solution, able to quantify CD16 negative monocytes, could be a useful tool to manage monocytosis which remains a common issue in routine laboratories.Methods: Classical monocytes were quantified from 153 whole blood samples collected on EDTA using both flow cytometry methods, either MO1 percentage determination by the multiparameter assay previously published and regarded here as the reference method, or CD16 negative monocyte percentage determination by the means of HematoFlow™.Results: Both methods of classical monocyte percentage determination were highly and significantly correlated (r = 0.87, P < 0.0001). The HematoFlow™ solution leant toward an overestimation of the genuine classical monocyte percentages obtained by the reference method. Percentages of CD16 negative monocytes provided by HematoFlow were higher than 94% for all the 73 patients displaying classical monocytes MO1 found ≥94% by the reference method, indicating a sensitivity of 100%. Furthermore, the calculation of CD16 negative monocyte percentage can be easily computerized and integrated to the middleware.Conclusions: We propose a new application of the Hematoflow™ solution that can be used as a flag system for monocytosis management and CMML detection.
Complete list of metadata

Cited literature [10 references]  Display  Hide  Download
Contributor : Laurent Jonchère Connect in order to contact the contributor
Submitted on : Tuesday, June 26, 2018 - 3:13:25 PM
Last modification on : Saturday, June 25, 2022 - 10:31:59 PM


Vazquez et al. - High sensitiv...
Files produced by the author(s)



Romain Vazquez, Mikaël Roussel, Bouchra Badaoui, Nicolas Freynet, Sihem Tarfi, et al.. High sensitivity of the Hematoflow™ solution for chronic myelomonocytic leukemia screening. Cytometry Part B: Clinical Cytometry, Wiley, 2018, 94 (5), pp.658-661. ⟨10.1002/cyto.b.21600⟩. ⟨hal-01812481⟩



Record views


Files downloads